Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock
BRISBANE, Calif., Oct. 29, 2024 ( GLOBE NEWSWIRE ) -- Vera Therapeutics, Inc. ( "Vera" ) , a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunologic diseases, today announced the pricing of an ...
| Ticker |
Sentiment |
Impact |
|
BR
|
Neutral
|
5 %
|
|
EVR
|
Neutral
|
11 %
|
|
GS
|
Neutral
|
11 %
|
|
VERA
|
Neutral
|
5 %
|
